THERAMetrics
Switzerland-based contract research and development organization providing technological solutions for drug discovery and clinical research.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
Related Content
THERAMetrics is a Swiss-based technology-driven Contract Research & Development Organization (TCRDO) specializing in innovative solutions across the drug discovery and development value chain. Headquartered in Stans, Switzerland, and now part of the Relief Therapeutics Group, THERAMetrics offers comprehensive services to biopharmaceutical companies, including virtual drug screening, therapy evaluation in simulated patient models, and prediction of real-world health outcomes and costs. The company leverages advanced in-silico platforms, such as its proprietary Drug Repurposing and Repositioning (DRR 2.0) system, which analyzes vast biomedical literature to identify new therapeutic uses for existing drugs and uncover hidden mechanisms of action. This platform supports pharmaceutical research by enabling expert scientists and decision-makers to explore connections between drugs and diseases, thereby accelerating innovation and reducing development risks.
THERAMetrics provides end-to-end clinical research services, covering early-stage First-In-Human trials through to large-scale Phase III-IV international studies. Their offerings include regulatory consulting, project management, site monitoring, data management, pharmacovigilance, biostatistics, and medical writing. The organization also operates its own clinical research units for Phase I and II studies, as well as bioequivalence trials, and manages clinical study supply logistics to streamline packaging, labeling, and distribution. With expertise spanning therapeutic areas such as oncology, immunology, CNS disorders, cardiovascular diseases, and rare/orphan drugs, THERAMetrics is recognized for its commitment to technological innovation, operational efficiency, and strategic partnerships within the global biopharma sector.
Keywords: drug discovery, clinical research, contract research organization, drug repurposing, in-silico screening, DRR 2.0, pharmaceutical innovation, biopharma, virtual biosystems, clinical trials, regulatory consulting, project management, pharmacovigilance, bioequivalence, Switzerland, Relief Therapeutics, orphan drugs, biomedical data analysis, translational medicine, therapeutic areas